PHARMACOLOGICAL TREATMENTS FOR PRIMARY SCLEROSING CHOLANGITIS: A NETWORK META-ANALYSIS

被引：0
|
作者：
Gurusamy, K. [1 ,2 ]
Saffioti, F. [3 ,4 ]
Toon, C. [1 ,2 ]
Davidson, B. [1 ,2 ]
Tsochatzis, E. [3 ,4 ]
Thorburn, D. [3 ,4 ]
机构：
[1] UCL, Surg, London, England
[2] Royal Free Hampstead NHS Trust, London, England
[3] Royal Free Hosp, Sheila Sherlock Liver Ctr, London NW3 2QG, England
[4] UCL Inst Liver & Digest Hlth, London, England
来源：
GUT | 2015年 / 64卷
关键词：
D O I：
10.1136/gutjnl-2015-309861.546
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PWE-097
引用
收藏
页码：A254 / A255
页数：2
相关论文
共 50 条
  • [1] Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis
    Triantos, C. K.
    Koukias, N. M.
    Nikolopoulou, V. N.
    Burroughs, A. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 901 - 910
  • [2] Incidence of Primary Sclerosing Cholangitis: a Systematic Review and Meta-Analysis
    Molodecky, Natalie A.
    Kareemi, Hashim
    Parab, Rohan
    Barkema, Herman W.
    Quan, Hude
    Myers, Robert P.
    Kaplan, Gilaad G.
    HEPATOLOGY, 2011, 53 (05) : 1590 - 1599
  • [3] APPENDECTOMY IS ASSOCIATED WITH AN INCREASED RISK OF PRIMARY SCLEROSING CHOLANGITIS: A META-ANALYSIS
    Rassameehiran, Supannee
    Leelasinjaroen, Pornchai
    Tetangco, Eula
    Sifuentes, Humberto
    Sridhar, Subbaramiah
    GASTROENTEROLOGY, 2018, 154 (06) : S1208 - S1208
  • [4] Ursodeoxycholic acid in primary sclerosing cholangitis: A systematic review and meta-analysis
    Othman, Mohamed O.
    Kaza, Archana
    Choudhary, Ablushek
    Bechtold, Matthew L.
    Puli, Srinivas R.
    Dunkelberg, Jeffrey C.
    Roy, Praveen K.
    GASTROENTEROLOGY, 2008, 134 (04) : A839 - A839
  • [5] Primary Sclerosing Cholangitis: Meta-Analysis of Diagnostic Performance of MR Cholangiopancreatography
    Dave, Maneesh
    Elmunzer, B. Joseph
    Dwamena, Ben A.
    Higgins, Peter D. R.
    RADIOLOGY, 2010, 256 (02) : 387 - 396
  • [6] A network meta-analysis of the efficacy and side effects of udca-based therapies for primary sclerosing cholangitis
    Zhu, Gui-Qi
    Shi, Ke-Qing
    Huang, Gui-Qian
    Wang, Li-Ren
    Lin, Yi-Qian
    Braddock, Martin
    Chen, Yong-Ping
    Zhou, Meng-Tao
    Zheng, Ming-Hua
    ONCOTARGET, 2015, 6 (29) : 26757 - 26769
  • [7] Emerging treatments for primary sclerosing cholangitis
    Rodriguez, Eduardo A.
    Carey, Elizabeth J.
    Lindor, Keith D.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (05) : 451 - 459
  • [8] Current treatments of primary sclerosing cholangitis
    Vacca, M.
    Krawczyk, M.
    Petruzzelli, M.
    Sasso, R. C.
    van Erpecum, K. J.
    Palasciano, G.
    vanBerge-Henegouwen, G. P.
    Moschetta, A.
    Portincasa, P.
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (19) : 2081 - 2094
  • [9] Systematic review and meta-analysis of risk factors for recurrent primary sclerosing cholangitis
    Korkmaz, Kerem Sebib
    Steenstraten, Iris
    Trivedi, Palak
    Inderson, Akin
    Van Hoek, Bart
    Girondo, Mar Rodriguez
    Maljaars, Jeroen
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E414 - E414
  • [10] EFFECTS OF SMOKING ON RISK OF PRIMARY SCLEROSING CHOLANGITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Rassameehiran, Supannee
    Leelasinjaroen, Pornchai
    Tetangco, Eula
    Sifuentes, Humberto
    GASTROENTEROLOGY, 2018, 154 (06) : S1208 - S1208
12345